Vima Therapeutics
Clinical trials sponsored by Vima Therapeutics, explained in plain language.
-
New hope for dystonia: experimental drug aims to ease muscle spasms
Symptom relief Recruiting nowThis study tests whether VIM0423 can reduce dystonia symptoms like muscle spasms and improve quality of life. About 100 adults with isolated dystonia affecting at least two body areas will receive either the drug or a placebo. The trial is double-blind, meaning neither participan…
Phase: PHASE2 • Sponsor: Vima Therapeutics • Aim: Symptom relief
Last updated May 17, 2026 12:58 UTC
-
New study aims to uncover how dystonia changes lives
Knowledge-focused Recruiting nowThis study watches how isolated dystonia (a movement disorder affecting multiple body areas) changes over time. Researchers will collect information from 200 people aged 12–65 to better understand symptoms, daily challenges, and quality of life. No treatments or drugs are given—j…
Sponsor: Vima Therapeutics • Aim: Knowledge-focused
Last updated May 17, 2026 12:54 UTC